Endothelium, ischemia and the good side of oxygen free radicals

Clinical Hemorheology and Microcirculation

Volumn 39, Issue 1-4, 2008, Pages 197-203

  Grotti, S ^a   Gori, T ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Endothelial dysfunction; Endothelium; Ischemia; Ischemic preconditioning; Nitric oxide; Oxygen free radicals; Reperfusion

Indexed keywords

OXYGEN RADICAL;

CONFERENCE PAPER; ENDOTHELIAL DYSFUNCTION; HUMAN; ISCHEMIA; REPERFUSION INJURY; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; ENDOTHELIUM, VASCULAR; FREE RADICALS; HUMANS; ISCHEMIA; ISCHEMIC PRECONDITIONING; MODELS, BIOLOGICAL; MODELS, THEORETICAL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; OXYGEN; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; RISK FACTORS;

EID: 47849089992     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2008-1082     Document Type: Conference Paper

References (56)

1. T. Gori, G. Di Stolfo, S. Sicuro, S. Dragoni, M. Lisi, J.D. Parker and S. Forconi, Correlation analysis between different parameters of conduit artery and microvascular vasodilation, Clin. Hemorheol. Microcirc. 35 (2006), 509-515.
2. S. Verma and T.J. Anderson, Fundamentals of endothelial function for the clinical cardiologist, Circulation 105 (2002), 546-549.
3. S. Verma, M.R. Buchanan and T.J. Anderson, Endothelial function testing as a biomarker of vascular disease, Circulation 108 (2003), 2054-2059.
4. J.A. Vita and J.F. Keaney, Jr., Endothelial function: a barometer for cardiovascular risk?, Circulation 106 (2002), 640-642.
5. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data, Circulation 68 (1983), 939-950.
6. R.M. Califf, H.R. Phillips, III, M.C. Hindman, D.B. Mark, K.L. Lee, V.S. Behar, R.A. Johnson, D.B. Pryor, R.A. Rosati and G.S. Wagner, Prognostic value of a coronary artery jeopardy score, J. Am. Coll. Cardiol. 5 (1985), 1055-1063.
7. Y. Taniguchi, M. Nakamura, T. Suzuki, T. Suzuki, H. Aoki and K.I. Fukami, A case of acute myocardial infarction: intracoronary thrombus formation at a previously provoked vasospasm site, Jpn. Heart J. 41 (2000), 761-766.
8. V. Schachinger, M.B. Britten and A.M. Zeiher, Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease, Circulation 101 (2000), 1899-1906.
9. J.A. Suwaidi, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Holmes, Jr. and A. Lerman, Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction, Circulation 101 (2000), 948-954.
10. J.P. Halcox, W.H. Schenke, G. Zalos, R. Mincemoyer, A. Prasad, M.A. Waclawiw, K.R. Nour and A.A. Quyyumi, Prognostic value of coronary vascular endothelial dysfunction, Circulation 106 (2002), 653-658.
11. P.V. Targonski, P.O. Bonetti, G.M. Pumper, S.T. Higano, D.R. Holmes, Jr. and A. Lerman, Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events, Circulation 107 (2003), 2805-2809.
12. F. Perticone, R. Ceravolo, A. Pujia, G. Ventura, S. Iacopino, A. Scozzafava, A. Ferraro, M. Chello, P. Mastroroberto, P. Verdecchia and G. Schillaci, Prognostic significance of endothelial dysfunction in hypertensive patients, Circulation 104 (2001), 191-196.
13. T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz and T. Munzel, Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease, Circulation 104 (2001), 2673-2678.
14. S.D. Katz, K. Hryniewicz, I. Hriljac, K. Balidemaj, C. Dimayuga, A. Hudaihed and A. Yasskiy, Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure, Circulation 111 (2005), 310-314.
15. T. Heitzer, S. von Baldus, Y. Kodolitsch, V. Rudolph and T. Meinertz, Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure, Arterioscler. Thromb. Vasc. Biol. 25 (2005), 1174-1179.
16. B. Meyer, D. Mortl, K. Strecker, M. Hulsmann, V. Kulemann, T. Neunteufl, R. Pacher and R. Berger, Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide, J. Am. Coll. Cardiol. 46 (2005), 1011-1018.
17. G. Brevetti, A. Silvestro, V. Schiano and M. Chiariello, Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index, Circulation 108 (2003), 2093-2098.
18. N. Gokce, J.F. Keaney, Jr., L.M. Hunter, M.T. Watkins, Z.S. Nedeljkovic, J.O. Menzoian and J.A. Vita, Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease, J. Am. Coll. Cardiol. 41 (2003), 1769-1775.
19. B. Takase, A. Hamabe, K. Satomura, T. Akima, A. Uehata, T. Matsui, F. Ohsuzu, M. Ishihara and A. Kurita, Comparable prognostic value of vasodilator response to acetylcholine in brachial and coronary arteries for predicting long-term cardiovascular events in suspected coronary artery disease, Circ. J. 70 (2006), 49-56.
20. J. Yeboah, J.R. Crouse, F.C. Hsu, G.L. Burke and D.M. Herrington, Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study, Circulation 115 (2007), 2390-2397.
21. C. Di Massimo, R. Lo Presti, C. Corbacelli, A. Pompei, P. Scarpelli, D. De Amicis, G. Caimi and M.G. Tozzi Ciancarelli, Impairment of plasma nitric oxide availability in senescent healthy individuals: apparent involvement of extracellular superoxide dismutase activity, Clin. Hemorheol. Microcirc. 35 (2006), 231-237.
22. F. Cosentino and E. Osto, Aging and endothelial dysfunction, Clin. Hemorheol. Microcirc. 37 (2007), 143-147.
23. G. Caimi, C. Carollo and R. Lo Presti, Chronic renal failure: oxidative stress, endothelial dysfunction and wine, Clin. Nephrol. 62 (2004), 331-335.
24. J.L. Zweier, J.T. Flaherty and M.L. Weisfeldt, Direct measurement of free radical generation following reperfusion of ischemic myocardium, Proc. Natl. Acad. Sci. USA 84 (1987), 1404-1407.
25. H. Kusuoka, M.C. Camilion de Hurtado and E. Marban, Role of sodium/calcium exchange in the mechanism of myocardial stunning: protective effect of reperfusion with high sodium solution, J. Am. Coll. Cardiol. 21 (1993), 240-248.
26. E.F. du Toit and L.H. Opie, Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion, Circ. Res. 70 (1992), 960-967.
27. K.A. Kaminski, T.A. Bonda, J. Korecki and W.J. Musial, Oxidative stress and neutrophil activation - the two keystones of ischemia/reperfusion injury, Int. J. Cardiol. 86 (2002), 41-59.
28. R.A. Kloner and R.B. Jennings, Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2, Circulation 104 (2001), 3158-3167.
29. T. Gori, G. Di Stolfo, S. Sicuro, S. Dragoni, J.D. Parker and S. Forconi, The effect of ischemia and reperfusion on microvascular function: a human in vivo comparative study with conduit arteries, Clin. Hemorheol. Microcirc. 35 (2006), 169-173.
30. S. Yusuf, G. Dagenais, J. Pogue, J. Bosch and P. Sleight, Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators, N. Engl. J. Med. 342 (2000), 154-160.
31. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, Lancet 354 (1999), 447-455.
32. J.M. Rapola, J. Virtamo, S. Ripatti, J.K. Huttunen, D. Albanes, P.R. Taylor and O.P. Heinonen, Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction, Lancet 349 (1997), 1715-1720.
33. N.G. Stephens, A. Parsons, P.M. Schofield, F. Kelly, K. Cheeseman and M.J. Mitchinson, Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet 347 (1996), 781-786.
34. D.H. Lee, A.R. Folsom, L. Harnack, B. Halliwell and D.R. Jacobs, Jr., Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes?, Am. J. Clin. Nutr. 80 (2004), 1194-1200.
35. I.D. Podmore, H.R. Griffiths, K.E. Herbert, N. Mistry, P. Mistry and J. Lunec, Vitamin C exhibits pro-oxidant properties, Nature 392 (1998), 559.
36. G.R. Dagenais, R. Marchioli, S. Yusuf and G. Tognoni, Beta-carotene, vitamin C, and vitamin E and cardiovascular diseases, Curr. Cardiol. Rep. 2 (2000), 293-299.
37. D.D. Waters, E.L. Alderman, J. Hsia, B.V. Howard, F.R. Cobb, W.J. Rogers, P. Ouyang, P. Thompson, J.C. Tardif, L. Higginson, V. Bittner, M. Steffes, D.J. Gordon, M. Proschan, N. Younes and J.I. Verter, Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial, JAMA 288 (2002), 2432-2440.
38. D.P. Vivekananthan, M.S. Penn, S.K. Sapp, A. Hsu and E.J. Topol, Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials, Lancet 361 (2003), 2017-2023.
39. C.E. Murry, R.B. Jennings and K.A. Reimer, Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium, Circulation 74 (1986), 1124-1136.
40. K. Shiki and D.J. Hearse, Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias, Am. J. Physiol. 253 (1987), H1470-H1476.
41. M.V. Cohen, G.S. Liu and J.M. Downey, Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits, Circulation 84 (1991), 341-349.
42. T. Gori and S. Forconi, The role of reactive free radicals in ischemic preconditioning - clinical and evolutionary implications, Clin. Hemorheol. Microcirc. 33 (2005), 19-28.
43. T. Gori, M. Lisi and S. Forconi, Ischemia and reperfusion: the endothelial perspective. A radical view, Clin. Hemorheol. Microcirc. 35 (2006), 31-34.
44. I. Tritto and G. Ambrosio, Role of oxidants in the signaling pathway of preconditioning, Antioxid. Redox. Signal. 3 (2001), 3-10.
45. R. Bolli, The late phase of preconditioning, Circ. Res. 87 (2000), 972-983.
46. F. Tomai, F. Crea, L. Chiariello and P.A. Gioffre, Ischemic preconditioning in humans: models, mediators, and clinical relevance, Circulation 100 (1999), 559-563.
47. R.A. Kloner, R. Bolli, E. Marban, L. Reinlib and E. Braunwald, Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop, Circulation 97 (1998), 1848-1867.
48. T. Gori, A. Daiber, G. Di Stolfo, S. Sicuro, S. Dragoni, M. Lisi, T. Munzel, S. Forconi and J.D. Parker, Nitroglycerine causes mitochondrial reactive oxygen species production: in vitro mechanistic insights, Can. J. Cardiol. 23(12) (2007), 990-992.
49. T. Gori, G. Di Stolfo, S. Sicuro, S. Dragoni, M. Lisi, S. Forconi and J.D. Parker, Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight, Br. J. Clin. Pharmacol. 64 (2007), 145-150.
50. G. Lebuffe, P.T. Schumacker, Z.H. Shao, T. Anderson, H. Iwase and T.L. Vanden Hoek, ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel, Am. J. Physiol. Heart Circ. Physiol. 284 (2003), H299-H308.
51. K. Laude, C. Thuillez and V. Richard, Peroxynitrite triggers a delayed resistance of coronary endothelial cells against ischemia-reperfusion injury, Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H1418-H1423.
52. R.D. Rakhit, R.J. Edwards, J.W. Mockridge, A.R. Baydoun, A.W. Wyatt, G.E. Mann and M.S. Marber, Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes, Am. J. Physiol. Heart Circ. Physiol. 278 (2000), H1211-H1217.
53. Y.S. Chen, C.T. Chien, M.C. Ma, Y.Z. Tseng, F.Y. Lin, S.S. Wang and C.F. Chen, Protection "outside the box" (skeletal remote preconditioning) in rat model is triggered by free radical pathway, J. Surg. Res. 126 (2005), 92-101.
54. S. Verma, A. Maitland, R.D. Weisel, P.W. Fedak, N.C. Pomroy, S.H. Li, D.A. Mickle, R.K. Li and V. Rao, Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation, J. Thorac. Cardiovasc. Surg. 123 (2002), 1074-1083.
55. A.L. Moens and D.A. Kass, Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease, J. Cardiovasc. Pharmacol. 50 (2007), 238-246.
56. S. Dragoni, T. Gori, G. Di Stolfo, S. Sicuro, S. Forconi and J.D. Parker, Folic acid does not limit endothelial dysfunction induced by ischemia and reperfusion: a human study, J. Cardiovasc. Pharmacol. 46 (2005), 494-497.